BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2018

Dec 21, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2018-12-20

Reporting Person: Barnes Alane P (Senior VP, Chief Legal Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-12-20	Emp. Stock Option (Right to Buy)	$7.06	A	190000	Acquired	2028-12-20	Common Stock (190000)	Direct

Footnotes

F1: Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.